Semaglutide-associated bullous pemphigoid.

JAAD case reports2021PMID: 34466645

View on PubMed DOI: 10.1016/j.jdcr.2021.07.027

Authors

Burruss, Clayton P; Jones, Jordan M; Burruss, Jyoti B

Keywords

BP, bullous pemphigoidDABP, drug-associated bullous pemphigoidDPP-4is, dipeptidyl peptidase-4 inhibitorsELISA, enzyme-linked immunosorbent assayGLP-1, glucagon-like peptide-1IIF, indirect immunofluorescenceIgG, immunoglobulin Gdiabetes mellitusdrug interactionsglucagon-like peptide-1pemphigoidsemaglutide